Original Research

Published on 19 Oct 2023

In vitro to clinical translation of combinatorial effects of doxorubicin and dexrazoxane in breast cancer: a mechanism-based pharmacokinetic/pharmacodynamic modeling approach

in Pharmacology of Anti-Cancer Drugs

Hardik Mody
Tanaya R. Vaidya
Jovin Lezeau
Kareem Taha
Sihem Ait-Oudhia

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1239141

1,883 views
4 citations

Brief Research Report

Published on 19 Oct 2023

Androgen deprivation therapy plus apalutamide as neoadjuvant therapy prior radical prostatectomy for patients with unresectable prostate cancer

in Pharmacology of Anti-Cancer Drugs

Yongbao Wei
Ruochen Zhang
Dewen Zhong
Zhensheng Chen
Gen Chen
Minggen Yang
Le Lin
Tao Li
Liefu Ye
Lili Chen

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1284899

2,343 views
1 citation

Review

Published on 18 Oct 2023

Compounds targeting ferroptosis in breast cancer: progress and their therapeutic potential

in Pharmacology of Anti-Cancer Drugs

Chuchu Xu
Yian Chen
Qinghong Yu
Jiaqing Song
Ying Jin
Xiufei Gao

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1243286

3,532 views
2 citations

Original Research

Published on 17 Oct 2023

Methotrexate-conjugated zinc oxide nanoparticles exert a substantially improved cytotoxic effect on lung cancer cells by inducing apoptosis

in Pharmacology of Anti-Cancer Drugs

Prakriti Mishra
Mohd Faizan Ali Ahmad
Lamya Ahmed Al-Keridis
Mohd Saeed
Nawaf Alshammari
Nadiyah M. Alabdallah
Rohit Kumar Tiwari
Afza Ahmad
Mahima Verma
Shireen Fatima

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1194578

2,541 views
4 citations

Review

Published on 16 Oct 2023

Research progress on the chemical components and biological activities of sea cucumber polypeptides

in Pharmacology of Anti-Cancer Drugs

Yiwen Shou
Chao Feng
Qinpei Lu
Xin Mao
Huisha Huang
Zhiheng Su
Hongwei Guo
Zhaoquan Huang

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1290175

2,891 views
4 citations

Case Report

Published on 13 Oct 2023

Case report: Remarkable response to sintilimab, lenvatinib, and nab-paclitaxel in postoperative metastatic chemotherapy-resistant combined hepatocellular-cholangiocarcinoma

in Pharmacology of Anti-Cancer Drugs

Nan Zhou
Chuan-Fen Lei
Si-Rui Tan
Qi-Yue Huang
Shun-Yu Zhang
Zheng-Xin Liang
Hong-Feng Gou

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1190967

2,460 views
5 citations

Methods

Published on 13 Oct 2023

Radius additivity score: a novel combination index for tumour growth inhibition in fixed-dose xenograft studies

in Pharmacology of Anti-Cancer Drugs

Nicola Melillo
Jake Dickinson
Lu Tan
Hitesh B. Mistry
Heinrich J. Huber

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1272058

2,333 views

Original Research

Published on 13 Oct 2023

Immunological role and prognostic value of somatostatin receptor family members in colon adenocarcinoma

in Pharmacology of Anti-Cancer Drugs

Xiaoqian Yu
Xuejie Yang
Hui Nie
Wenying Jiang
Xiaoyun He
Chunlin Ou

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1255809

1,642 views
1 citation

Review

Published on 11 Oct 2023

The double-edged sword role of hydrogen sulfide in hepatocellular carcinoma

in Pharmacology of Anti-Cancer Drugs

Huijie Zhao
Yanting Zhang
Xiaodi Fu
Chaoren Chen
Saadullah Khattak
Honggang Wang

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1280308

2,215 views
4 citations

Original Research

Published on 06 Oct 2023

Design and synthesis of cabotegravir derivatives bearing 1,2,3-triazole and evaluation of anti-liver cancer activity

in Pharmacology of Anti-Cancer Drugs

Huaxia Xie
Longfei Mao
Gaolu Fan
Ziyuan Wu
Yimian Wang
Xixi Hou
Jiangang Wang
Huili Wang
Ling Liu
Sanqiang Li

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1265289

2,247 views
2 citations

Original Research

Published on 04 Oct 2023

YIV-818-A: a novel therapeutic agent in prostate cancer management through androgen receptor downregulation, glucocorticoid receptor inhibition, epigenetic regulation, and enhancement of apalutamide, darolutamide, and enzalutamide efficacy

in Pharmacology of Anti-Cancer Drugs

Wing Lam
Mohammad Arammash
Wei Cai
Fulan Guan
Zaoli Jiang
Shwu-Huey Liu
Peikwen Cheng
Yung-Chi Cheng

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1244655

3,353 views

Review

Published on 04 Oct 2023

An overview of the past decade of bufalin in the treatment of refractory and drug-resistant cancers: current status, challenges, and future perspectives

in Pharmacology of Anti-Cancer Drugs

Qingmei Ye
Xin Zhou
Han Ren
Fangxuan Han
Rong Lin
Juan Li

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1274336

2,343 views
5 citations

Original Research

Published on 04 Oct 2023

Phenethyl isothiocyanate and dasatinib combination synergistically reduces hepatocellular carcinoma growth via cell cycle arrest and oxeiptosis

in Pharmacology of Anti-Cancer Drugs

Gabriele Strusi
Caterina M. Suelzu
Nicole Horwood
Andrea E. Münsterberg
Yongping Bao

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1264032

2,112 views
4 citations

Review

Published on 03 Oct 2023

Engineered biomaterial delivery strategies are used to reduce cardiotoxicity in osteosarcoma

in Pharmacology of Anti-Cancer Drugs

Yulin Hou
Jie Wang
Jianping Wang

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1284406

1,740 views
3 citations

Correction

Published on 29 Sep 2023

Corrigendum: Cucurbitacin-B instigates intrinsic apoptosis and modulates Notch signaling in androgen-dependent prostate cancer LNCaP cells

in Pharmacology of Anti-Cancer Drugs

Ahmed Alafnan
Nasrin E. Khalifa
Talib Hussain
Mhdia Elhadi Osman

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1286507

1,276 views

Review

Published on 28 Sep 2023

Lipid metabolism as a target for cancer drug resistance: progress and prospects

in Pharmacology of Anti-Cancer Drugs

Zi’an Wang
Yueqin Wang
Zeyun Li
Wenhua Xue
Shousen Hu
Xiangzhen Kong

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1274335

4,370 views
7 citations

Navigation group

Articles

In vitro to clinical translation of combinatorial effects of doxorubicin and dexrazoxane in breast cancer: a mechanism-based pharmacokinetic/pharmacodynamic modeling approach

Androgen deprivation therapy plus apalutamide as neoadjuvant therapy prior radical prostatectomy for patients with unresectable prostate cancer

Compounds targeting ferroptosis in breast cancer: progress and their therapeutic potential

Methotrexate-conjugated zinc oxide nanoparticles exert a substantially improved cytotoxic effect on lung cancer cells by inducing apoptosis

Research progress on the chemical components and biological activities of sea cucumber polypeptides

Case report: Remarkable response to sintilimab, lenvatinib, and nab-paclitaxel in postoperative metastatic chemotherapy-resistant combined hepatocellular-cholangiocarcinoma

Radius additivity score: a novel combination index for tumour growth inhibition in fixed-dose xenograft studies

Immunological role and prognostic value of somatostatin receptor family members in colon adenocarcinoma

The double-edged sword role of hydrogen sulfide in hepatocellular carcinoma

Design and synthesis of cabotegravir derivatives bearing 1,2,3-triazole and evaluation of anti-liver cancer activity

YIV-818-A: a novel therapeutic agent in prostate cancer management through androgen receptor downregulation, glucocorticoid receptor inhibition, epigenetic regulation, and enhancement of apalutamide, darolutamide, and enzalutamide efficacy

An overview of the past decade of bufalin in the treatment of refractory and drug-resistant cancers: current status, challenges, and future perspectives

Phenethyl isothiocyanate and dasatinib combination synergistically reduces hepatocellular carcinoma growth via cell cycle arrest and oxeiptosis

Engineered biomaterial delivery strategies are used to reduce cardiotoxicity in osteosarcoma

Corrigendum: Cucurbitacin-B instigates intrinsic apoptosis and modulates Notch signaling in androgen-dependent prostate cancer LNCaP cells

Lipid metabolism as a target for cancer drug resistance: progress and prospects